Forssman glycolipid hapten variants of dog gastric mucosa  by Slomiany, Amalia et al.
Volume 81, number 1 FEBS LETTERS September 1977 
FORSSMAN GLYCOLIPID HAPTEN VARIANTS OF DOG GASTRIC MUCOSA 
Amalia SLOMIANY, Bronislaw L. SLOMIANY and Carlo ANNESE 
Gastroenterology Research Laboratory, Departments of Medicine and Biochemistry, New York Medical College, 
New York, NY 10029, USA 
Received 4 July 1977 
1. Introduction 
Forssman hapten is a genetically defined hetero- 
philic antigen that specifically inhibits the reaction 
between sheep erythrocytes and anti-sheep ery- 
throcyte antibody derived from different species. 
This antigen, first described by Forssman [ I] has 
been shown to be a glycosphingolipid [2-41 The 
structure of this glycolipid, earlier thought to be a 
tetraglycosylceramide, was later established as a 
pentaglycosylceramide [5] and shown to be common 
for the hapten isolated from various sources [6-81 . 
Variation with regard to the internal carbohydrate 
chain of Forssman glycolipid has been also reported 
PI. 
In this study, three water-soluble glycolipids 
containing N-acetylgalactosamine and exhibiting 
Forssman activity were isolated from dog gastric 
mucosa. One of the isolated glycolipids was found 
to be a pentaglycosylceramide with identical sugar 
composition to that of Forssman hapten. The other 
two were heptaglycosylceramide and octaglycosyl- 
ceramide. 
2. Experimental 
2.1. Materials 
Dog stomachs used for mucosa preparation were 
obtained from Pel-Freez Biological (Rogers, AR). 
Heterophile Forssman antiserum was from Difco 
Laboratories (Detroit, MI) and IDF cells for micro- 
immunodiffusion from Cordis Laboratories (Miami, 
FL). DEAE-Sephadex A-25 was supplied by 
Pharmacia (Piscataway, NJ) and silicic acid (100-200 
mesh) by Bio-Rad Laboratories (Richmond, CA). 
North-Holland Publishing Company - Amsterdam 
Silica-gel HR plates, 250 nm coating thickness were 
purchased from Analtech (Newark, DE). Human red 
cells A, B, 0 types, human blood-grouping serum 
anti-A, anti-B and anti-H (Alex europeus extract) 
were from Biological Corporation of America 
(Port Reading, NJ). 
2.2. Isolation of water-soluble glycolipids 
Extraction of lipids from dog gastric mucosa 
scrapings was performed by the tetrahydrofuran 
procedure [IO,1 11. The aqueous phase was concen- 
trated to a small volume, dialyzed and lyophilized. 
The crude glycolipid fraction contained in the 
lyophilizate was dissolved in propan-l -ol/isopropanol/ 
NH40H (35:35:30 v/v/v) and chromatographed on 
silicic acid column [ 121. Fractions, 5 ml, were 
collected and every fifth was monitored for glyco- 
lipids by thin-layer chromatography. The eluates 
showing the same chromatographic pattern were 
pooled to give three different fractions (I, II and III). 
Each fraction was dialyzed, lyophilized, dissolved in 
methanol/chloroform/water (60:30:8 v/v/v) and 
separately applied to a column of’DEAE-Sephadex 
[ 131. The neutral glycolipids were eluted from the 
column with the above mixture and the gangliosides 
and other acidic lipids, with 0.2 M sodium acetate 
in methanol/chloroform/water (60:30:8 v/v/v). The 
neutral glycolipid fractions were then subjected to 
mild alkaline methanolysis [ 141 , dialysis and lyophili- 
zation. The final purification of the glycolipids 
contained in the lyophilizates was accomplished by 
preparative thin-layer chromatography in chloroform/ 
methanol/water (60:35:8 v/v/v), chloroform/ 
methanol/NHGOH (40:80:25 v/v/v) and chloroform/ 
methanol/acetic acid/water (55:45:5:5 v/v/v/v). 
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2.3. Analytical methods 
Thin-layer chromatography was performed on 
silica-gel HR plates activated at 130°C for 1 h. Neutral 
glycolipids were visualized with orcinol, gangliosides 
with resorcinol and sulfatides with rhodizonate [ 151 . 
Iodine was used for preparative purposes. 
Methyl esters of fatty acids and methyl glycosides 
were obtained by methanolysis of the glycolipids in 
1.2 M methanolic HCl at 85°C for 20 h. Hexosamines 
were re-ZV-acetylated with acetic anhydride [ 121. The 
alditol acetate derivatives of monosaccharides were 
obtained from the glycolipids according to the 
procedure of Yang and Hakomori [ 161. 
Gas-liquid chromatography was performed with a 
Beckman GC-65 instrument equipped with glass 
columns 6 ft X l/8 in packed with 3% SE-30 on 
chromosorb, W, AW, DMCS (So-100 mesh), and 
packed with 1% ECNSS-M on Gas Chrom-Q. The 
alditol acetates were analyzed on ECNSS-M columns 
programmed at 2”C/min from 150&2 10°C. For the 
analysis of trimethylsilyl derivatives of methyl glyco- 
sides on SE-30 columns, the temperature was pro- 
grammed at l”C/min. from 140-210°C. The long- 
chain bases were quantitized as described previously 
[ 1 l] Removal of fucose residue from fucose- 
containing glycolipid was accomplished by hydrolysis 
in 0.1 M trichloroacetic acid at 100°C for 2 h. 
2.4. Immunological assays 
Hemagglutination and hemagglutination-inhibition 
assays were performed with the Takatsy microtitrator 
using 0.025 ml loops and 2% suspension of human 
red cells. The anti-A and anti-B serums were diluted 
to 4 units/O.025 ml, the anti-H was commercially 
available at potency of 2 units/O.025 ml. Forssman 
hapten activity was tested by a double diffusion 
micromethod as described by Wadsworth [ 171 . The 
wells were filled with 10 ~1 undiluted antiserum and 
10 yl 1 mg/ml solutions of the glycolipids in saline. 
All immunological assays were performed in the 
presence of ten-fold excess of a mixture of lecithin- 
cholesterol (1: 1) as auxiliary lipids [ 181 . 
3. Results 
Each fraction from silicic acid column contained 
one major and several minor neutral glycolipids. The 
major components were purified to homogeneity on 
thin-layer plates to give three glycolipids (I, II and III). 
Glycolipid I was eluted from silicic acid column 
mainly in fraction I. Fraction II contained glycolipid 
II and fraction III contained glycolipid III. The 
relative migration rates (RF) of the isolated glyco- 
lipids are given in table 1. The yields of the purified 
glycolipids (fig.1) per 100 g wet gastric mucosa 
scrapings were: glycolipid I, 3.9 mg.; glycolipid II, 
2.4 mg.; glycolipid III, 1 .I mg. 
The composition and molar ratio of carbohydrates 
present in the isolated glycolipids is given in table 2. 
Glucose, galactose and N-acetylgalactosamine in a 
molar ratio of 1:2:2 were found in glycolipid I. The 
same carbohydrates, but in a molar ratio of 1:3:3, 
were present in glycolipid II. The carbohydrate portion 
of glycolipid III revealed the presence of glucose 
fucose, galactose and N-acetylgalactosamine in a molar 
Table 1 
Relative migration rates (RF) of the purified glycolipids 
Solvent system RF Values of 
Glycolipid I Glycolipid II Glycolipid III 
Chloroform/methanol/water 
(65:35:8 v/v/v) 
Chloroform/methanol/NH,OH 
(40:80:25 v/v/v) 
Chloroform/methanol/acetic acid/ 
water (55:45:5:5 v/v/v/v) 
0.25 0.22 0.18 
0.47 0.42 0.15 
0.40 0.41 0.22 
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Fig.1. Thin-layer chromatography of the purified glycolipids 
with Forssman activity. (1) Glycolipid Ill; (2) glycolipid I; 
(3) glycolipid Il. Conditions: silica-gel HR-250 nm developed 
in chloroform/methanol/water (60:35:8 v/v/v). Visualiza- 
tion: orcinol reagent. 
ratio of 1: 1: 3: 3. The above data indicate that the 
glycolipid I is a pentaglycosylceramide, glycolipid II, 
heptaglycosylceramide and glycolipid III, 
octaglycosylceramide. Partial acid hydrolysis of 
glycolipid III (defucosylation) resulted in a glycolipid 
which corresponded in its chromatographic behavior 
and sugar compositions to that of glycolipid II. 
In the double diffusion micromethod, all three 
glycolipids gave a single precipitation line with anti- 
Forssman antiserum. In the presence of auxiliary lipids, 
all three glycolipids were equally reactive and, accord- 
ing to the precipitation pattern, showed identity. In 
hemagglutination-inhibition assays all three glycolipids 
completely inhibited agglutination of human group-A 
red cells by human anti-A serum at concentration of 
Table 2 
The composition and molar ratios of carbohydrates in the 
isolated glycolipids 
~__ 
Glycolipid Molar ratios 
Fuc Gal Glc GalNAc 
Glycolipid 1 - 1.98 1.0 1.95 
Glycolipid 11 - 2.91 1.0 2.97 
Glycolipid Ill 0.98 2.95 1.0 2.91 
2.5-5.0 pg. Furthermore, glycolipid III also showed 
strong activity in H anti-H system, This activity was 
completely abolished by the removal of fucose 
(partial hydrolysis). 
4. Discussion 
Dog gastric and intestinal mucosa has been recog- 
nized for some time as an exceptionally rich source of 
pentaglycosylceramide [19,201 . This glycolipid was 
shown to have the antigenic activity and structure 
identical with that of horse spleen Forssman glyco- 
lipid hapten, i.e., GalNAca(l+3)GalNAcfl(l+3) 
Gal~(l-+4)Gal/3(l+4)Glc(l-+l)ceramide [S-8]. 
Recent studies on glycolipids of hamster fibroblasts 
[9] indicate that this antigen exists in the cultured 
cells in two polymorphic variations with regard to its 
internal carbohydrate chain. Both variants, however, 
share the common terminal structure composed of 
three sugar residues, GalNAcm( 1-+3)GalNAc/3( 1-+3)Gal 
Our data indicates that Forssman glycolipid hapten 
of dog gastric mucosa exists at least in three different 
structural forms, with the pentaglycosylceramide 
being predominant. It is apparent that glycolipids I, 
II and III must share the common terminal structure 
which determines the immunological specificity of 
Forssman antigen. Furthermore, all three glycolipids 
exhibited blood-group A activity which is in accor- 
dance with the results obtained by other investigators 
[21] and is thought to be due to the presence of 
terminal a-N-acetylgalactosaminyl residue in both the 
Forssman antigen and blood group-A determinant. 
The H-activity of glycolipid III could be explained 
only if the carbohydrate portion of this compound 
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consisted of a branched saccharide chain with the 
~-N-acetylgalactosaminyl(l+3)/3-N-acetylgalactos- 
aminyl and a-L-fucosyl-( 1+2)&galactosyl residues 
being terminal. That the H-activity resides in the 
latter disaccharide portion of the glycolipid III is 
supported further by the results of partial acid 
hydrolysis. Defucosylation of glycolipid III resulted 
in the loss of its H-activity, but had no effect on its 
reactivity with Forssman antiserum nor on its ability 
to inhibit hemagglutination in A anti-A system. 
Accordingly, the glycolipid II which differs from 
glycolipid III only in one sugar residue, i.e., fucose, 
probably consists of two non-reducing termini, 
~-N-acetylgalactosaminyl-(l-t31P_N-acetylgalactos- 
amine and galactose. Our recent structural studies 
[ 121 support this assumption. 
The presence of multiple forms of glycolipids 
carrying blood-group determinants in gastrointestinal 
tract of mammals is well established [22-241. Also, 
existence of the glycolipids of a branched structure 
carrying more than one antigenic determinant has 
been reported [ 13,241 It has been suggested earlier 
by Rapport and Graf [21] that the Forssman antigen 
may not be a single compound. The data presented in 
this report indicate that Forssman glycolipid hapten 
exists as a number of variants. 
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